IVERIC bio, Inc. Net Cash Provided by (Used in) Continuing Operations
IVERIC bio, Inc. reported Net Cash Provided by (Used in) Continuing Operations of -$41.38 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2017-05-03
- IVERIC bio, Inc. net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was -$41.38M.
- IVERIC bio, Inc. net cash provided by (used in) continuing operations for the quarter ending 2016-12-31 was -$31.67M.
- IVERIC bio, Inc. net cash provided by (used in) continuing operations for the quarter ending 2016-09-30 was -$28.45M, a 113.04% decline year-over-year.
- IVERIC bio, Inc. net cash provided by (used in) continuing operations for the quarter ending 2016-06-30 was $10.23M.
- IVERIC bio, Inc. net cash provided by (used in) continuing operations for fiscal 2016 was -$87.93M, a 148.30% decline from fiscal 2015.
- IVERIC bio, Inc. net cash provided by (used in) continuing operations for fiscal 2015 was $182.05M.
- IVERIC bio, Inc. net cash provided by (used in) continuing operations for fiscal 2014 was -$170.78M, a 182.79% decline from fiscal 2013.
- IVERIC bio, Inc. net cash provided by (used in) continuing operations for fiscal 2013 was $206.29M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month | Net Cash Provided by (Used in) Continuing Operations 81 month | Net Cash Provided by (Used in) Continuing Operations 84 month | Net Cash Provided by (Used in) Continuing Operations 87 month |
|---|---|---|---|---|---|---|---|
| 2017-03-31 | -$41.38M 10-Q · filed 2017-05-03 | -$73.05M derived: sum of 2 quarters · filed 2017-05-03 | -$101.50M derived: sum of 3 quarters · filed 2017-05-03 | -$91.27M derived: sum of 4 quarters · filed 2017-05-03 | |||
| 2016-12-31 | -$31.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$60.12M derived: sum of 2 quarters · filed 2017-02-28 | -$49.89M derived: sum of 3 quarters · filed 2017-02-28 | -$87.93M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | -$28.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$18.22M derived: sum of 2 quarters · filed 2016-11-08 | -$56.26M 10-Q · filed 2016-11-08 | -$89.29M derived: sum of 4 quarters · filed 2017-05-03 | |||
| 2016-06-30 | $10.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$27.81M 10-Q · filed 2016-08-05 | -$60.84M derived: sum of 3 quarters · filed 2017-05-03 | $157.33M derived: sum of 4 quarters · filed 2017-05-03 | |||
| 2016-03-31 | -$38.04M 10-Q · filed 2017-05-03 | -$71.07M derived: sum of 2 quarters · filed 2017-05-03 | $147.10M derived: sum of 3 quarters · filed 2017-05-03 | $144.25M derived: sum of 4 quarters · filed 2017-05-03 | |||
| 2015-12-31 | -$33.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $185.14M derived: sum of 2 quarters · filed 2017-02-28 | $182.29M derived: sum of 3 quarters · filed 2017-02-28 | $182.05M 10-K · filed 2017-02-28 | |||
| 2015-09-30 | $218.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $215.33M derived: sum of 2 quarters · filed 2016-11-08 | $215.08M 10-Q · filed 2016-11-08 | $160.09M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | -$2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$3.09M 10-Q · filed 2016-08-05 | -$58.08M derived: sum of 3 quarters · filed 2017-02-28 | -$211.78M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | -$246.00K 10-Q · filed 2016-05-09 | -$55.24M derived: sum of 2 quarters · filed 2017-02-28 | -$208.93M derived: sum of 3 quarters · filed 2017-02-28 | -$26.99M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | -$54.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$208.68M derived: sum of 2 quarters · filed 2017-02-28 | -$26.75M derived: sum of 3 quarters · filed 2017-02-28 | -$170.78M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | -$153.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $28.24M derived: sum of 2 quarters · filed 2015-11-05 | -$115.79M 10-Q · filed 2015-11-05 | -$141.28M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-06-30 | $181.94M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-10 | $37.90M 10-Q · filed 2015-08-10 | $12.42M derived: sum of 3 quarters · filed 2016-02-26 | $208.65M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-03-31 | -$144.03M 10-Q/A · filed 2015-07-28 | -$169.52M derived: sum of 2 quarters · filed 2016-02-26 | $26.71M derived: sum of 3 quarters · filed 2016-02-26 | $64.36M derived: sum of 4 quarters · filed 2016-02-26 | $66.56M 10-Q · filed 2014-05-13 | ||
| 2013-12-31 | -$25.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $170.74M derived: sum of 2 quarters · filed 2016-02-26 | $208.40M derived: sum of 3 quarters · filed 2016-02-26 | $206.29M 10-K · filed 2016-02-26 | $210.60M 10-K · filed 2014-03-11 | ||
| 2013-09-30 | $196.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $233.88M derived: sum of 2 quarters · filed 2014-11-12 | $231.78M 10-Q · filed 2014-11-12 | $231.73M derived: sum of 4 quarters · filed 2015-07-28 | $236.08M 10-Q · filed 2013-11-13 | ||
| 2013-06-30 | $37.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $35.55M 10-Q · filed 2014-08-06 | $35.51M derived: sum of 3 quarters · filed 2015-07-28 | ||||
| 2013-03-31 | -$2.10M 10-Q · filed 2014-05-13 | -$2.15M derived: sum of 2 quarters · filed 2015-07-28 | |||||
| 2012-12-31 | -$42.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-07-28 | -$2.09M 10-K/A · filed 2015-07-28 | |||||
| 2012-09-30 | -$2.05M 10-Q · filed 2013-11-13 | ||||||
| 2011-12-31 | -$733.00K 10-K · filed 2014-03-11 |